Gemcor Information

What's inside Gemcor

Gemcor in the News

Rand Capital's Portfolio Rises in Value - Black Enterprise
The Buffalo venture capital firm said Monday that Gemcor's growth prompted it to increase the value of its investment in the company, which is benefiting ...
Tue Feb 05 20:59:29 -0500 2008

Rand Capital Announces Fourth Quarter Increase in Net Assets - CNNMoney.com
During the fourth quarter of 2007, Rand's Net Asset Value increased by $0.49, which primarily reflects the revaluation of Gemcor II, LLC, (www.gemcor.com), ...
Mon Feb 04 15:42:01 -0500 2008

Rand Capital Announces Fourth Quarter Increase in Net Assets - CNNMoney.com
During the fourth quarter of 2007, Rand's Net Asset Value increased by $0.49, which primarily reflects the revaluation of Gemcor II, LLC, (www.gemcor.com), ...
Mon Feb 04 15:42:01 -0500 2008

Gemcor Chemical Information

gemfibrozil - A fibric acid derivative with hypolipidemic effects. Gemfibrozil interacts with peroxisome proliferator-activated receptors (PPARalpha) resulting in PPARalpha-mediated stimulation of fatty acid oxidation and an increase in lipoprotein lipase (LPL) synthesis. This enhances triglyceride-rich lipoprotein clearance and reduces the expression of apolipoprotein C-III (apoC-III). The reduction in hepatic production of apoC-III results in subsequent reduction of serum levels of very-low-density-lipoprotein cholesterol (VLDL-C). In addition, gemfibrozil-mediated PPARalpha stimulation of apoA-I and apoA-II expression results in an increase in high-density lipoprotein cholesterol (HDL-C).